Comparison of Bacteriuria, Hematuria, and Pain Complications after Transrectal and Transperineal Prostate Biopsy in Patients with Suspected Prostate Cancer

Kurnia Penta Seputra; Harry Achsan  Chaerul; Besut Daryanto; Dewi Santosaningsih; Khairul Asri Mohd  Ghani

doi:10.11594/bjurology.2026.007.01.5

Authors

Kurnia Penta Seputra Department of Urology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia, 65112
Harry Achsan Chaerul Department of Urology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia, 65112
Besut Daryanto Department of Urology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia, 65112
Dewi Santosaningsih Department of Clinical Microbiology, Faculty of Medicine Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia, 65112
Khairul Asri Mohd Ghani Department of Urology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia, 43400

DOI:

https://doi.org/10.11594/bjurology.2026.007.01.5

Keywords:

bacteriuria, hematuria, pain, biopsy

Abstract

Introduction. Prostate cancer is the most common cancer in men with the second-highest mortality rate in the United States. In Indonesia, 1,102 patients with an average age of 67.18 years have been diagnosed with prostate cancer in the last 8 years. The primary diagnostic approach for prostate cancer involves two biopsy methods: transrectal prostate biopsy (TRPB) and transperineal prostate biopsy (TPPB). This study aims to evaluate the complications of bacteriuria, hematuria, and pain levels after the procedures between TRPB and TPPB.

Methods. This study is an analytical observational study with a cohort design. The sample consists of 34 patients suspected of prostate cancer, undergoing prostate biopsy with a 1:1 technique comparison between TPPB (17) and TRPB (17). Data were analyzed using SPSS software version 28.

Result. The Friedman test and paired T-test results show a significant difference in urine culture and urinalysis before and after transrectal biopsy, but no significant difference in pain assessment. For transperineal biopsy, a significant difference was only found in pain assessment before and after the biopsy. The Mann-Whitney test results show a significant difference in the incidence of bacteriuria and hematuria, with TPPB showing lower rates and higher VAS in the TPPB group.

Conclusion. TPPB tends to be better at avoiding the risk of bleeding and infection complications, while TRPB is better at avoiding pain. Therefore, TPPB is more beneficial for patients.

References

Triwiyanto, IDGHW, Sumber, EY. Embedded Web server of Uroflow Meter Based on IoT Technology. 2021 International Seminar on Application for Technology of Information and Communication (iSemantic). 2021:161-6. doi: 10.1109/iSemantic52711.2021.9573201

Xiang J, Yan H, Li J, Wang J, Chen H, Zheng X. Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis. World J Surg Oncol. 2019;17(1):31. doi: 10.1186/s12957-019-1573-0

Williamson DA, Barrett LK, Rogers BA, Freeman JT, Hadway P, Peterso DL. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis. 2013;57(2):267-274. doi: 10.1093/cid/cit193

Ortner G, Tzanaki E, Rai BP, Nagele U, Tokas T. Transperineal prostate biopsy: The modern gold standard to prostate cancer diagnosis. Turk J Urol. 2021; 47:S19-S26. doi: 10.5152/tud.2020.20358

Halfian R, Soebadi DM, Rizaldi F. Comparison Between Transrectal Ultrasonography Guided Transrectal Prostate Biopsy and Transrectal Ultrasonography Guided Transperineal Prostate Biopsy. Indonesian Journal of Urology. 2019;26(2):160-5. doi: 10.32421/juri.v26i2.505

Liu X, Yu C, Bi Y, Zhang ZJ. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China. Public Health. 2019;172:70-80. doi: 10.1016/j.puhe.2019.04.016

Pernar CH, Ebot EM, Wilson KM, Mucci LA. The Epidemiology of Prostate Cancer. Cold Spring Harb Perspect Med. 2018;8:1-18. doi: 10.1101/cshperspect.a030361

Di Franco CA, Jallous H, Porru D, et al. A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer. Arch Ital Urol Androl. 2017; 89:55-9. doi: 10.4081/aiua.2017.1.55.ww

Lowrance WT, Breau RH, Chou R, Chapin BF, Crispino T, Dreicer R, et al. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. J Urol. 2021;205(1):14-21. doi: 10.1097/JU.0000000000001375

Saito K, Washino S, Nakamura Y, Konishi T, Ohshima M, Arai Y, Miyagawa T. Transperineal ultrasound-guided prostate biopsy is safe even when patients are on combination antiplatelet and/or anticoagulation therapy. BMC Urol. 2017; 17(1):53. doi: 10.1186/s12894-017-0245-z

Pirola GM, Gubbiotti M, Rubilotta E, Castellani D, Trabacchin N, Tafuri A, et al. Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study. Prostate Int. 2022; 10:34-7. doi: 10.1016/j.prnil.2021.11.001

Huang GL, Kang CH, Lee WC, Chiang PH. Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches - a single center preliminary study. BMC Urol. 2019;19(1):101. doi: 10.1186/s12894-019-0539-4

Bass EJ, Donaldson IA, Freeman A, Jameson E, Punwani S, Moore C, et al. Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach. Prostate Cancer Prostatic Dis. 2017;20(3):311-7. doi: 10.1038/pcan.2017.13

Jones TA, Radtke JP, Hadaschik B, Marks LS. Optimizing safety and accuracy of prostate biopsy. Curr Opin Urol. 2016; 26(5):472-80. doi: 10.1097/MOU.0000000000000310

Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. Complications After Systematic, Random, and Image-guided Prostate Biopsy. Eur Urol. 2017;71(3):353-65. doi: 10.1016/j.eururo.2016.08.004

Marra G, Marquis A, Tappero S, D’Agate D, Oderda M, Calleris G, et al. Transperineal Free-hand mpMRI Fusion-targeted Biopsies Under Local Anesthesia: Technique and Feasibility From a Single-center Prospective Study. Urology. 2020; 140:122-31. doi: 10.1016/j.urology.2019.11.078

Sivaraman A, Ramasamy V, Aarthy P, Sankar V, Sivaraman PB. Safety and feasibility of freehand transperineal prostate biopsy under local anesthesia: Our initial experience. Indian J Urol. 2022;38(1):34-41. doi: 10.4103/iju.iju_222_21

Örtegren J, Wimmerstedt A, Åberg D, Janson H, Kjölhede H, Kahlmeter G, et al. Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy. Eur Urol Open Sci. 2022;48:54-9. doi: 10.1016/j.euros.2022.11.024

Bennett HY, Roberts MJ, Doi SA, Gardiner RA. The global burden of major infectious complications following prostate biopsy. Epidemiol Infect. 2016;144(8):1784-91. doi: 10.1017/S0950268815002885

Yaghi MD, Kehinde EO. Oral antibiotics in trans-rectal prostate biopsy and its efficacy to reduce infectious complications: Systematic review. Urol Ann. 2015;7(4):417-27. doi: 10.4103/0974-7796.164860

Skouteris VM, Crawford ED, Mouraviev V, Arangua P, Metsinis MP, Skouteris M, et al. Transrectal Ultrasound-guided Versus Transperineal Mapping Prostate Biopsy: Complication Comparison. Rev Urol. 2018;20(1):19-25. doi: 10.3909/riu0785

Lohr JA, Downs SM, Schlager TA. Urinary Tract Infections. Principles and Practice of Pediatric Infectious Disease: Third Edition, 2009;30:343–7. doi: 10.1016/B978-0-7020-3468-8.50057-2

Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Front Microbiol. 2017;8:1566. doi: 10.3389/fmicb.2017.01566

Huang Z, Wu L, Zeng M, Wu B, Xu X, Mao H, et al. Value of urine/serum Neutrophil gelatinase-associated lipocalin ratio in distinguishing acute kidney injury from chronic kidney disease. Clin Chim Acta. 2022;526:23-9. doi: 10.1016/j.cca.2021.12.018

Rosario DJ, Lane JA, Metcalfe C, Donovan JL, Doble A, et al. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ. 2012;344:d7894. doi: 10.1136/bmj.d7894

Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876-92. doi: 10.1016/j.eururo.2013.05.049

Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int. 2004; 94(7):1014-20. doi: 10.1111/j.1464-410X.2004.05096.x

Chowdhury R, Abbas A, Idriz S, et al. Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes. Clin Radiol. 2012;67(12):e64-70. doi: 10.1016/j.crad.2012.08.005

Eineluoto JT, Järvinen P, Kilpeläinen T, Lahdensuo K, Kalalahti I, Sandeman K, et al. Patient Experience of Systematic Versus Fusion Prostate Biopsies. Eur Urol Oncol. 2018;1(3):202-7. doi: 10.1016/j.euo.2018.02.005

Adibi M, Hornberger B, Bhat D, Raj G, Roehrborn CG, Lotan Y. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol. 2013;189(2):535-40. doi: 10.1016/j.juro.2012.08.194

Su R, Pan JF, Huang RD, Tao ZL, Yu CL, Jiang JH, et al. Feasibilities and outcomes of patients treated with simultaneous prostate biopsy and general urological surgeries. Exp Ther Med. 2022;25(1):31. doi: 10.3892/etm.2022.11729

Gilberto GM, Arcuri MF, Falsarella PM, Mariotti GC, Lemos PLA Neto, Garcia RG. Complication rates of transrectal and transperineal prostate fusion biopsies - is there a learning curve even in high volume interventional center? Int Braz J Urol. 2023; 49(3):334-40. doi: 10.1590/S1677-5538.IBJU.2023.0054

Hogan D, Kanagarajah A, Yao HH, Wetherell D, Dias B, Dundee P, et al. Local versus general anesthesia transperineal prostate biopsy: Tolerability, cancer detection, and complications. BJUI Compass. 2021;2(6):428-35. doi: 10.1002/bco2.106